CDT Equity enters SAFE note investment in Pep'd with $10 million valuation cap
CDT•SAFE investment in Pep'd
CDT Equity entered into a SAFE with U.S.-based peptide company Pep'd, positioning for minority equity exposure via automatic conversion at the next equity financing.
The SAFE converts into Safe Preferred Stock based on Pep'd capitalization at conversion, subject to a $10 million valuation cap.
The transaction expands CDT’s exposure to the U.S. peptide market, with plans to apply AI-enabled approaches to peptide development.
Pep'd is controlled by CDT CEO Andrew Regan, who is also a director of CDT.
